Home Pharmaceuticals COVID-19 Diagnostics Market Size, Share & Growth Chart by 2033

COVID-19 Diagnostics Market Size & Outlook, 2025-2033

COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Kits, Services), By Sample Type (Nasopharyngeal (NP) swabs, Oropharyngeal (OP) swabs, Nasal swabs, Blood, Others), By Mode of Testing (Molecular Testing(PCR), Antigen-based Testing, Serology Testing (Antibody), Others), By End-Users (Laboratories, Hospitals, Diagnostic Centers and Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH1215DR
Last Updated : Aug, 2025
Pages : 110
Author : Mitiksha Koul
Format : PDF, Excel

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global COVID-19 Diagnostics Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. COVID-19 Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Hologic Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific, Inc.
    3. Hoffman-La Roche Ltd.
    4. Perkin Elmer, Inc.
    5. Laboratory Corporation of America Holdings (LabCorp)
    6. bioMérieux SA
    7. Danaher
    8. Mylab Discovery Solutions Pvt. Ltd.
    9. Neuberg Diagnostics
    10. Quest Diagnostics
    11. Abbott
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :